Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Randomization Period: Up to 3 Years	STARTED	Gilteritinib	247
Randomization Period: Up to 3 Years	STARTED	Salvage Chemotherapy	124
Randomization Period: Up to 3 Years	Treated	Gilteritinib	246
Randomization Period: Up to 3 Years	Treated	Salvage Chemotherapy	109
Randomization Period: Up to 3 Years	COMPLETED	Gilteritinib	0
Randomization Period: Up to 3 Years	COMPLETED	Salvage Chemotherapy	19
Randomization Period: Up to 3 Years	NOT COMPLETED	Gilteritinib	247
Randomization Period: Up to 3 Years	NOT COMPLETED	Salvage Chemotherapy	105
Long Term Follow up: up to 3 Years	STARTED	Gilteritinib	133
Long Term Follow up: up to 3 Years	STARTED	Salvage Chemotherapy	73
Long Term Follow up: up to 3 Years	COMPLETED	Gilteritinib	0
Long Term Follow up: up to 3 Years	COMPLETED	Salvage Chemotherapy	0
Long Term Follow up: up to 3 Years	NOT COMPLETED	Gilteritinib	133
Long Term Follow up: up to 3 Years	NOT COMPLETED	Salvage Chemotherapy	73

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02421939/flow